<?xml version="1.0" encoding="UTF-8"?>
<ref id="B129-pharmaceuticals-12-00157">
 <label>129.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Deng</surname>
    <given-names>Y.Q.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>N.N.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>C.F.</given-names>
   </name>
   <name>
    <surname>Tian</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hao</surname>
    <given-names>J.-N.</given-names>
   </name>
   <name>
    <surname>Xie</surname>
    <given-names>X.-P.</given-names>
   </name>
   <name>
    <surname>Shi</surname>
    <given-names>P.-Y.</given-names>
   </name>
   <name>
    <surname>Qin</surname>
    <given-names>C.-F.</given-names>
   </name>
  </person-group>
  <article-title>Adenosine analog NITD008 is a potent inhibitor of Zika virus</article-title>
  <source>Open Forum Infect. Dis.</source>
  <year>2016</year>
  <volume>3</volume>
  <elocation-id>ofw175</elocation-id>
  <pub-id pub-id-type="doi">10.1093/ofid/ofw175</pub-id>
  <?supplied-pmid 27747251?>
  <pub-id pub-id-type="pmid">27747251</pub-id>
 </element-citation>
</ref>
